German company CureVac has received a rather strange offer from the current White House.
On March 3, CureVac's CEO was invited to the White House, for a meeting with President Trump, Vice Pence and several members of the Coronavirus Task Force. Asked for when a vaccine could be ready, he estimated that a potential candidate could be ready within a few months. Apparently, that triggered the members of the meeting so much, that they've now offered to buy the company, at whatever price.
One condition though: production would be exclusively for the United States.
The move is not exactly one to gain popularity, and follows on the heels of the President's worrying statement that "a large number of new clusters in the United States were seeded by travelers from Europe".
(Score: 4, Interesting) by choose another one on Monday March 16 2020, @01:37PM
More complicated than that even.
The COVID19 fatalities are related to immune/inflammatory system over-reaction - i.e. cytokine storm.
A good immune system may actually be a liability, doctors tend to have a good immune system, but young doctors in China are among the dead.
Masks are ineffective, and may be worse than useless, unless used properly, which most untrained (and some trained) people don't.
Handwashing, disintfecting contact points, most people can do right and even not-quite-right is a lot better than nothing.
Best is stay away from other people though.